Anest. intenziv. Med. 2008;19(2):110-119

Epidemiology of invasive candidiasis and candidemia - a persistent problemIntensive Care Medicine - Original Paper

Haber Jan1,*, Mallátová Naďa2, Kolešková Evženie1, Hnátková Markéta1, Kořen Jan1, Herold Ivan3
1 I. interní klinika - hematoonkologie VFN a 1. LF UK Praha
2 Centrální laboratoře Nemocnice České Budějovice, a. s.
3 Anesteziologicko-resustitační oddělení, Oblastní nemocnice Mladá Boleslav, a. s.

During the last decades fungal infections have become a serious complication with a significant impact on the length of hospital stay and mortality in hospitalized patients. Candida infections occur not only in neutropenic patients with haematological malignancies but also in patients with other forms of immune deficiency e.g. in those undergoing abdominal surgery, solid organ transplantations and those admitted to the ICU. The growing incidence of candida infections dates from the early 1980s to the late 1990s. The introduction of fluconazole resulted in a slow decrease in the incidence of candidiasis and a lower occurrence of Candida albicans infections, and a relatively higher incidence of infections caused by non- albicans Candida species. In spite of this the mortality remains high at 40-50% on some wards. In order to achieve better treatment results, better diagnostic tools and new antifungal agents are needed but greater awareness and better education of the medical staff are also essential.

Keywords: invasive candidiasis; candidiasis; incidence; mortality; risk factors; candidemia; transplantation

Received: January 7, 2008; Accepted: January 13, 2008; Published: April 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Haber J, Mallátová N, Kolešková E, Hnátková M, Kořen J, Herold I. Epidemiology of invasive candidiasis and candidemia - a persistent problem. Anest. intenziv. Med. 2008;19(2):110-119.
Download citation

References

  1. Nucci, M., Anaissie, E. Revisiting the source of candidemia: skin or gut? Clin. Infect. Dis., 2001, 33, p. 1959-1967. Go to original source... Go to PubMed...
  2. Pfaller, M. A., Diekema, D. J. Role of sentinel surveillance of candidemia: trends in species distribution and antifungal susceptibility. J. Clin. Microbiol., 2002, 40, p. 3551-3557. Go to original source... Go to PubMed...
  3. Beck-Sagué, C., Jarvis, W. R. Secular Trends in the Epidemiology of Nosocomial Fungal Infections in the United States, 1980-1990. National Infections Surveillance system. J. Infect. Dis., 1993, 167, p. 1247-1251. Go to original source... Go to PubMed...
  4. Weinberger, M., Sacks, T., Sulkes, J., Shapiro, M., Polacheck, I. Increasing fungal isolation from clinical specimens: experience in a university hospital over a decade. J. Hosp. Infect., 1997, 35, 3, p. 185-195. Go to original source... Go to PubMed...
  5. Banerjee, S. N., Emori, T. G., Culver, D. H. et al. Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. National Nosocomial Infections Surveillance System. Am. J. Med., 1991, 16, 91, 3B, p. 86S-89S. Go to original source... Go to PubMed...
  6. Pfaller, M., Wenzel, R. Impact of the changing epidemiology of fungal infections in the 90's. Eur. J. Clin. Microbiol. Infect. Dis., 1992, 11, 4, p. 287-291. Go to original source... Go to PubMed...
  7. Almirante, B., Rodriguez, D., Park, B. J. et al. Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, Barcelona, Spain, from 2002 to 2003. J. Clin. Microbiol., 2005, 43, 4, p. 1829-1835. Go to original source... Go to PubMed...
  8. Pfaller, M. A., Jones, R. N., Messer, S. A., Edmond, M. B., Wenzel, R. P. National surveillance of nosocomial blood stream infection due to species of Candida other than Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. Diagn. Microbiol. Infect. Dis., 1998, 30, p. 121-129. Go to original source... Go to PubMed...
  9. Wisplinghoff, H., Bischoff, T., Tallent, S. M. et al. Nosocomial Bloodstream Infections in US Hospitals: Analysis of 24,179 Cases from a Prospective Nationwide Surveillance Study. Clin. Infect. Dis., 2004, 39, p. 309-317. Go to original source... Go to PubMed...
  10. Spencer, R. C. Predominant pathogens found in the European Prevalence of Infection in Intensive Care Study. Eur. J. Clin. Microbiol. Infect. Dis., 1996, 15, 4, p. 281-285. Go to original source... Go to PubMed...
  11. Abi-Said, D., Anaissie, E., Uzun, O. et al. The epidemiology of hematogenous candidiasis by different Candida species. Clin. Infect. Dis., 1997, 24, p. 1122-1128. Go to original source... Go to PubMed...
  12. Goodman, J. L., Winston, D. J., Greenfield, R. A. et.al. A Controlled Trial of Fluconazole to Prevent Fungal Infections in Patients Undergoing Bone Marrow Transplantation. N. Engl. J. Med., 1992, 326, 13, p. 845-851. Go to original source... Go to PubMed...
  13. Gudlaugsson, O., Gillespie, S., Lee, K. et al. Attributable mortality of nosocomial candidemia, revisited. Clin. Infect. Dis., 2003, 37, p. 1172-1177. Go to original source... Go to PubMed...
  14. Sendid, B., Cotteau, A., François, F. et al. Candidaemia and antifungal therapy in a French University Hospital: rough trends over a decade and possible links. BMC Infect. Dis., 2006, 6, p. 80-89. Go to original source... Go to PubMed...
  15. Hobson, R. P. The global epidemiology of invasive Candida infections-is the tide turning? J. Hosp. Infect., 2003, 55, 3, p. 159-168. Go to original source... Go to PubMed...
  16. McNeil, M. M., Nash, S. L., Hajjeh, R. A. et al. Trends in Mortality Due to Invasive Mycotic Diseases in the United States, 1980-1997. Clin. Infect. Dis., 2001, 33, p. 641-647. Go to original source... Go to PubMed...
  17. Slavin, M. A., Osborne, B., Adams, R. et al. Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation - a prospective, randomized, double-blind study. J. Infect. Dis., 1995, 171, 6, p. 1545-1552. Go to original source... Go to PubMed...
  18. Marr, K. A., Seidel, K., White, T. C., Bowden, R. A. Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the administration of prophylactic fluconazole. J. Infect. Dis., 2000, 181, p. 309-316. Go to original source... Go to PubMed...
  19. Marr, K. A., Seidel, K., Slavin, M. A. et al. Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogenetic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial. Blood, 2000, 96, 6, p. 2055-2061. Go to original source...
  20. Marr, K. A. Invasive Candida Infections: The Changing Epidemiology. Oncology (Williston Park), 2004, 18, 14 (Suppl. 13), p. 9-14.
  21. Pagano, L., Caiara, M., Nosari, A. et al. Fungal Infections in Recipients of Hematopoietic Stem Cell Transplants: Results of the SEIFEM B-2004 Study. Clin. Infect. Dis., 2007, 45, p. 1161-1170. Go to original source... Go to PubMed...
  22. Trick, W. E., Fridkin, S. K., Edwards, J. R. et al. and National Nosocomial Infections Surveillance System Hospitals Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999. Clin. Infect. Dis., 2002, 35, p. 627-630. Go to original source... Go to PubMed...
  23. Bedini, A., Venturell, C., Mussini, C. et al. Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital. Clin. Microbiol. Infect., 2006, 12, 1, p. 75-80. Go to original source... Go to PubMed...
  24. Rotstein, C., Bow, E. J., Lavardiere, M. et al. Randomized placebo-controlled trial of fluconazole prophylaxis for neutropenic cancer patients: benefit based on purpose and intensity of cytotoxic therapy. The Canadian Fluconazole Prophylaxis Study Group. Clin. Infect. Dis., 1999, 28, 2, p. 331-340. Go to original source... Go to PubMed...
  25. Winston, D. J., Pakrasi, A., Busuttil, R. W. Prophylactic fluconazole in liver transplant recipients. A randomized, double-blind, placebo-controlled trial. Ann. Intern. Med., 1999, 16, 131, 10, p. 729-737. Go to original source... Go to PubMed...
  26. Pfaller, M. A., Diekema, D. J. Epidemiology of invasive candidiasis: a persistent public health problem. Clin. Microbiol. Rev., 2007, 20, 1, p. 133-163. Go to original source... Go to PubMed...
  27. Wey, S. B., Mori, M., Pfaller, M. A. et al. Hospital-acquired candidemia. Arch. Intern. Med., 1988, 148, p. 2642-2645. Go to original source... Go to PubMed...
  28. Diekema, D. J., Messer, S. A., Brueggemann, A. B. et al. Epidemiology of Candidemia: 3-Year Results from the Emerging Infections and the Epidemiology of Iowa Organisms Study. J. Clin. Microbiol., 2002, 40, 4, p. 1298-1302. Go to original source... Go to PubMed...
  29. Hajjeh, R. A., Sofair, A. N., Harrison, L. H. et al. Incidence of Bloodstream Infections Due to Candida Species and In Vitro Susceptibilities of Isolates Collected from 1998 to 2000 in a Population-Based Active Surveillance Program. J. Clin. Microbiol., 2004, 42, 4, p. 1519-1527. Go to original source... Go to PubMed...
  30. Weinberger, M., Leibovici, L., Perez, S. et al. Characteristics of candidaemia with Candida-albicans compared with non-albicans Candida species and predictors of mortality. J. Hosp. Infect., 2005, 61, 2, p. 146-154. Go to original source... Go to PubMed...
  31. Ben-Abraham, R., Keller, N., Teodorovitch, N. et al. Predictors of adverse outcome from candidal infection in a tertiary care hospital. J. Infect., 2004, 49, 4, p. 317-323. Go to original source... Go to PubMed...
  32. Asmundsdottir, L. R., Erlendsdottir, H., Gottfredsson, M. Increasing incidence of candidemia: results from a 20-year nationwide study in Iceland. J. Clin. Microbiol., 2002, 40, p. 3489-3492. Go to original source... Go to PubMed...
  33. Poikonen, E., Lyytikäinen, O., Anttila, V. J., Ruutu, P. Candidemia in Finland, 1995-1999. Emerg. Infect. Dis., 2003, 9, 8, p. 985-990. Go to original source... Go to PubMed...
  34. Sandven, P. L., Bevanger, A., Digranes, P. et al. Constant low rate of fungemia in Norway, 1991 to 1996. J. Clin. Microbiol., 1998, 36, 12, p. 3455-3459. Go to original source... Go to PubMed...
  35. Richet, H., Roux, P., Des Champs, C. et al. and French Candidemia Study Group Candidemia in French hospitals: incidence rates and characteristics. Clin. Microbiol. Infect., 2002, 8, p. 405-412. Go to original source... Go to PubMed...
  36. Martin, D., Persat, F., Piens, M. A., Picot, S. Candida species distribution in bloodstream cultures in Lyon, France, 1998-2001. Eur. J. Clin. Microbiol. Infect. Dis., 2005, 24, p. 329-333. Go to original source... Go to PubMed...
  37. Rodriguez, D., Almirante, B., Park, B. et al. Candidemia in Neonatal Intensive Care Units: Barcelona. Spain Pediatric Inf. Disease J., 2006, 25, 3, p. 224-229. Go to original source... Go to PubMed...
  38. Kao, A. S., Brandt, M. E., Pruitt, W. R. et al. The epidemiology of candidemia in two United States cities: results of a population-based active surveillance. Clin. Infect. Dis.,1999, 29, p. 1164-1170. Go to original source... Go to PubMed...
  39. Yamamura, D. L., Rotstein, C., Nicolle, L. E., Ioannou, S. Candidemia at selected Canadian sites: results from the Fungal Disease Registry, 1992-1994. Can. Med. Assoc. J., 1999, 23,160, 4, p. 493-499.
  40. Pfaller, M. A., Jones, R. N., Doern, G. V. et al. International surveillance of bloodstream infections due to Candida species: frequency of occurrence and antifungal susceptibilities of isolates collected in 1997 in the United States, Canada, and South America for the SENTRY Program. J. Clin. Microbiol., 1998, 36, 7, p. 1886-1889. Go to original source... Go to PubMed...
  41. Pretti, N., Malani, Suzanne F., Bradley, Rhonda S., Little, Carol A., Kauffman Trends in species causing fungaemia in a tertiary care medical centre over 12 years. Mycoses, 2001, 44, 11-12, p. 446-449. Go to original source... Go to PubMed...
  42. Bodey, G. P., Mardani, M., Hanna, H. et al. The epidemiology of Candida glabrata and Candida albicans fungemia in immunocompromised patients with cancer. Am. J. Med., 2002, 112, 5, p. 380-385. Go to original source... Go to PubMed...
  43. Antoniadou, A., Torres, H. A., Lewis, R. P. et al. Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy. Medicine (Baltimore), 2003, 82, 5, p. 309-321. Go to original source... Go to PubMed...
  44. Pfaller, M. A., Jones, R. N., Doern, G. V. et al. Bloodstream Infections Due to Candida Species: SENTRY Antimicrobial Surveillance Program in North America and Latin America, 1997-1998. Antimicrob. Agents Chemother., 2000, 44, 3, p. 747-751. Go to original source... Go to PubMed...
  45. Pfaller, M. A., Jones, R. N., Doern, G. V. et al. International surveillance of blood stream infections due to Candida species in the European SENTRY program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents. Diagn. Microbiol. Infect. Dis., 1999, 35, 1, p. 19-25. Go to original source... Go to PubMed...
  46. Luzzati, R., Amalfitano, G., Lazzarini, L. et al. Nosocomial candidemia in non-neutropenic patients at an Italian tertiary care hospital. Eur. J. Clin. Microbiol. Infect. Dis., 2000, 19, 8, p. 602-607. Go to original source... Go to PubMed...
  47. Pappas, P. G., Rex, J. H., Lee, J. et al. A Prospective Observational Study of Candidemia: Epidemiology, Therapy, and Influences on Mortality in Hospitalized Adult and Pediatric Patients. Clin. Infect. Dis., 2003, 37, p. 634-643. Go to original source... Go to PubMed...
  48. Pemán, J., Cantón, E., Gobernado, M. and the Spanish ECMM Working Group on Candidaemia Eur. J. Clin. Microbiol. Infect. Dis., 2005, 24, p. 23-30. Go to original source... Go to PubMed...
  49. Marchetti, O., Bille, J., Fluckiger, U. et al. Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991-2000. Clin. Infect. Dis., 2004, 38, p. 311-320. Go to original source... Go to PubMed...
  50. Viscoli, C., Girmenia, C., Marinus, A. et al. Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC). Clin. Infect. Dis., 1999, 28, p. 1071-1079. Go to original source... Go to PubMed...
  51. Viudes, A., Peman, J., Canton, E. et al. Candidemia at a tertiary-care hospital: epidemiology, treatment, clinical outcome and risk factors for death. Eur. J. Clin. Microbiol. Infect. Dis., 2002, 21, p. 767-774. Go to original source... Go to PubMed...
  52. Kibbler, C. C., Seaton, S., Barnes, R. A. et al. Management and outcome of bloodstream infections due to Candida species in England and Wales. J. Hosp. Infect., 2003, 54, 1, p. 18-24. Go to original source... Go to PubMed...
  53. Cuenca-Estrella, M., Rodriguez, D., Almirante, B. et al. In vitro susceptibilities of bloodstream isolates of Candida species to six antifungal agents: results from a population-based active surveillance programme, Barcelona, Spain, 2002-2003. J. Antimicrob. Chemother., 2005, 55, 2, p. 194-199. Go to original source... Go to PubMed...
  54. Arendrup, M. C., Fuursted, K., Gahrn-Hansen, B. et al. Seminational Surveillance of Fungemia in Denmark: Notably High Rates of Fungemia and Numbers of Isolates with Reduced Azole Susceptibility. J. Clin. Microbiol., 2005, 43, 9, p. 4434-4440. Go to original source... Go to PubMed...
  55. Buchta, V., Kolář, M., Bergerová, T. et al. Výskyt potenciálně patogenních kvasinek v krvi a moči pacientů ve velkých nemocnicích v České republice. Klin. Mikrobiol. Inf. Lék., 1998, 4, p. 10-17.
  56. Hamal, P., Dobiášová, S., Kocmanová, I. Candidemia in large Czech hospitals, 2000-2002: an epidemiological study. 15th Congress of the International Society for Human and Animal Mycology, San Antonio, 2003, p. 463.
  57. Hamal, P., Kocmanová, I., Jedličková, A. et al. Epidemiological analysis of candidemia in Czech tertiary care hospitals in 2000-2006. J. Chemother., 2007, 19, (Suppl. 3), p. S61-S62.
  58. Montravers, P., Jabbour, K. Clinical consequences of resistant Candida infections in intensive care. Int. J. Antimicrob. Agents, 2006, 27, 1, p. 1-6. Go to original source... Go to PubMed...
  59. Pagano, L., Mele, L., Fianchi, L. et al. Chronic disseminated candidiasis in patients with hematologic malignancies. Clinical features and outcome of 29 episodes. Haematologica, 2002, 87, p. 535-541. Go to PubMed...
  60. Vincent, J. L., Anaissie, E., Bruining, H. et al. Epidemiology, diagnosis and treatment of systemic candida infection in surgical patients under intensive care. Intensive Care Med., 1998, 24, p. 206-216. Go to original source... Go to PubMed...




Anesteziologie a intenzivní medicína

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.